Telios Pharmaceuticals Inc

Telios Pharmaceuticals, Inc. develops therapeutic products based upon pioneering research into the role of the extracellular matrix. The Company is applying its proprietary technology to develop products for the treatment of severe and chronic dermal wounds, opthalmic wounds, fibrotic disease, cardiovascular dis- ease and osteoporosis. The Company is in clinical trials of two such products.